Lineage switch to acute myeloid leukemia during induction chemotherapy for early T-cell precursor acute lymphoblastic leukemia with the translocation t(6;11)(q27;q23)/KMT2A-AFDN: A case report

Leuk Res. 2022 Jan:112:106758. doi: 10.1016/j.leukres.2021.106758. Epub 2021 Nov 25.

¹ Regional Children's Hospital, Ekaterinburg, Russian Federation; Ural State Medical University, Ekaterinburg, Russian Federation.
² National Medical Research Center of Pediatric Hematology, Oncology and Immunology, 1 Samory Mashela St., 117998, Moscow, Russia. Electronic address: uralcytometry@gmail.com.
³ Regional Children's Hospital, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.
⁴ Regional Children's Hospital, Ekaterinburg, Russian Federation.
⁵ Charles University, CLIP, Prague, Czech Republic; Motol University Hospital, Prague, Czech Republic.
⁶ Institute of Pharmaceutical Biology/DCAL, Goethe-University of Frankfurt, Frankfurt am Main, Germany.
⁷ Regional Children's Hospital, Ekaterinburg, Russian Federation; Ural State Medical University, Ekaterinburg, Russian Federation; Research Institute of Medical Cell Technologies, Ekaterinburg, Russian Federation.

No abstract available

Keywords: Acute myeloid leukemia; Early T-cell precursor leukemia; KMT2A-AFDN; Lineage switch.

Publication types